Patent - Abbreviated New Drug Application Cases filed in Delaware
Cases 1 - 10 of 20
Astellas Pharma Inc. et al v. Aurobindo Pharma Ltd. et al
as 1:2021cv00425
Defendant: Teva Pharmaceuticals USA, Inc., Cadila Healthcare Ltd. doing business as Zydus Cadila, Actavis LLC and others
Plaintiff: Astellas Pharma Global Development, Inc., Astellas Pharma Inc. and Astellas Ireland Co., Ltd.
Cause Of Action: 35 U.S.C. § 271
Astellas Pharma Inc. et al v. Sandoz Inc. et al We have downloadable decisions or orders for this case
as 1:2020cv01589
Defendant: Sawai Pharmaceutical Co., Ltd., Cadila Healthcare Ltd. doing business as Zydus Cadila, Apotex Inc. and others
Plaintiff: Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al We have downloadable decisions or orders for this case
as 1:2020cv00804
Defendant: Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd. and others
Plaintiff: Sanofi Mature IP and Sanofi-Aventis U.S. LLC
Cause Of Action: 35 U.S.C. § 271
UCB, Inc. et al v. Actavis Laboratories UT, Inc. We have downloadable decisions or orders for this case
as 1:2019cv00474
Plaintiff: UCB Pharma GmbH, UCB, Inc. and LTS Lohmann Therapie-Systeme AG
Defendant: Actavis Laboratories UT, Inc.
Cause Of Action: 35 U.S.C. § 271
Duchesnay Inc. v. Actavis Laboratories FL, Inc. et al
as 1:2018cv01895
Defendant: Teva Pharmaceuticals USA, Inc., Actavis Laboratories FL, Inc. and Teva Pharmaceutical Industries Ltd.
Plaintiff: Duchesnay Inc.
Cause Of Action: 35 U.S.C. § 271
Novartis Pharmaceuticals Corporation v. Accord Healthcare Inc. et al We have downloadable decisions or orders for this case
as 1:2018cv01043
Defendant: Emcure Pharmaceuticals, Torrent Pharmaceuticals Ltd., Mylan Pharmaceuticals, Inc. and others
Counter Claimant: Biocon Limited, HEC Pharm Group, HEC Pharm Co., Ltd. and others
Counter Defendant: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novartis Pharmaceuticals Corporation v. Teva Pharmaceuticals USA, Inc., et al.
as 1:2018cv01039
Defendant: Teva Pharmaceuticals USA, Inc. and Actavis Elizabeth LLC
Plaintiff: Novartis Pharmaceuticals Corporation
Cause Of Action: 35 U.S.C. § 1
Noven Pharmaceuticals, Inc. v. Actavis Laboratories UT, Inc.
as 1:2018cv00758
Defendant: Actavis Laboratories UT, Inc.
Plaintiff: Noven Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271
Indivior Inc. et al v. Actavis Laboratories UT, Inc. We have downloadable decisions or orders for this case
as 1:2018cv00497
Plaintiff: Indivior Inc. , Indivior UK Limited and Aquestive Therapeutics, Inc.
Defendant: Actavis Laboratories UT, Inc.
Cause Of Action: 35 U.S.C. § 271
LEO Pharma A/S et al v. Actavis Laboratories UT, Inc.
as 1:2018cv00402
Plaintiff: LEO Pharma A/S , LEO Laboratories Limited and LEO Pharma, Inc.
Defendant: Actavis Laboratories UT, Inc.
Cause Of Action: 35 U.S.C. § 271

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?